使用CRISPR/Cas9技术生成一种FAM189A2/ENTREP1淘汰人类诱导的多能干细胞系
Sibylle Marteau1, Laetitia Duboscq-Bidot2, Takanori Aizawa2
1iPS Core Facility, Institute of Cardiometabolism and Nutrition (ICAN), F-75013 Paris, France.
Stem cell research
|October 25, 2025
概括
研究人员通过创建基因失活的人类干细胞系来探索EREP1蛋白的功能. 这项工作旨在了解REP1的意义.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- FAM189A2/ENTREP1编码的是跨膜蛋白EREP1,在甲状腺,心脏,骨肌肉和质细胞中表达出显著水平.
- EREP1与各种癌症和心脏代谢疾病有关,这表明它具有重要的生理作用.
- EREP1激活ITCH,一种E3泛基因酶,对内体体动力学和蛋白质贩运至关重要.
研究的目的:
- 为了调查人们对EREP1蛋白的功能不太了解.
- 为了产生人类诱导多能干细胞 (hiPSCs) 带有无效FAM189A2 / ENTREP1基因的干细胞,用于功能研究.
主要方法:
- 使用了CRISPR/Cas9基因编辑技术.
- 人类诱导多能干细胞 (hiPSCs) 系由FAM189A2 / ENTREP1中的复合异构缺失产生,导致基因失效.
主要成果:
- 成功生成了一条具有双FAM189A2/ENTREP1删除的hiPSC线.
- 这种工程细胞系为研究EREP1在人体细胞中的功能提供了一个模型.
结论:
- 生成的hiPSC线为剖析EREP1.1的分子机制和生理作用提供了有价值的工具.
- 使用这种模型系统的进一步研究将阐明EREP1在细胞过程和疾病病理方面的参与.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...


